Search
for
Sort by
Research 391–420 of 1000+
- Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
- CHEMISTRY AND SIGNIFICANCE OF CHEMOPREVENTIVE NUTRACEUTICALS: A REVIEW
- Functional analysis of thymosin beta-4 using over-expressing transgenic mice
- Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation
- Redefining hormone resistance in prostate cancer
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation
- EXPERIENCES OF CANCER PATIENTS RECEIVING CHEMOTHERAPY IN ONCOLOGY FACILITIES: A SCOPING REVIEW PROTOCOL v1
- Slow progress in prostate cancer
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Cancer risk by the subtype of alopecia
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Prostate cancer update: 2007
- Areata progressing to totalis: A 24-month journey of hair regrowth at Dr. Batra’s
- Male pattern baldness and risk of incident skin cancer in a cohort of men
- Dermatologic Adverse Events from Cancer Treatments
- Tracing the cellular origin of cancer
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- MSF-VMDNet for multi class segmentation of skin cancer whole slide images using a multi frequency dual encoder network
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization